The most in-depth look yet at endometrial cancer shows that adding genomics-based testing to the standard diagnostic workup could change the recommended course of treatment for some women. The new research is published in the journal Nature. Pictured are endometrial cancer cells under a microscope.
Innovative, high-priority research initiatives by Washington University scientists at the Alvin J. Siteman Cancer Center are now under way thanks to a $7.5 million grant from Emerson and AT&T. Emerson’s Charitable Trust and the AT&T Foundation are contributing $5 million and $2.5 million, respectively. This commitment will generate an additional $15 million for these initiatives through matching support from Washington University School of Medicine, BJC HealthCare and the Siteman Cancer Center.
The National Cancer Institute has awarded Siteman Cancer Center and Washington University School of Medicine a prestigious Specialized Program of Research Excellence grant in endometrial cancer.